A Molecular Take on Malignant Rhabdoid Tumors. Tang, M. & Verhaak, R. G. Trends Cancer, 2(5):217-218, 2016. 2405-8033 Tang, Ming Verhaak, Roel Gw P01 CA085878/CA/NCI NIH HHS/United States R01 CA190121/CA/NCI NIH HHS/United States Comment Journal Article United States 2016/09/28 Trends Cancer. 2016 May;2(5):217-218. doi: 10.1016/j.trecan.2016.04.003.
doi  abstract   bibtex   
The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular inter-tumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic and epigenomic profiling. Distinct molecular subgroups were identified and new therapeutic targets were revealed.
@article{RN6122,
   author = {Tang, M. and Verhaak, R. G.},
   title = {A Molecular Take on Malignant Rhabdoid Tumors},
   journal = {Trends Cancer},
   volume = {2},
   number = {5},
   pages = {217-218},
   note = {2405-8033
Tang, Ming
Verhaak, Roel Gw
P01 CA085878/CA/NCI NIH HHS/United States
R01 CA190121/CA/NCI NIH HHS/United States
Comment
Journal Article
United States
2016/09/28
Trends Cancer. 2016 May;2(5):217-218. doi: 10.1016/j.trecan.2016.04.003.},
   abstract = {The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular inter-tumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic and epigenomic profiling. Distinct molecular subgroups were identified and new therapeutic targets were revealed.},
   keywords = {malignant rhabdoid tumors
molecular analysis
pediatric cancer
sequencing},
   ISSN = {2405-8033 (Print)
2405-8025},
   DOI = {10.1016/j.trecan.2016.04.003},
   year = {2016},
   type = {Journal Article}
}

Downloads: 0